CS241002B2 - Method of 2-acyl-4-oxo-haxahydro-4h-pyrazino-(2,1-a-)isoquinoline derivatives preparation - Google Patents

Method of 2-acyl-4-oxo-haxahydro-4h-pyrazino-(2,1-a-)isoquinoline derivatives preparation Download PDF

Info

Publication number
CS241002B2
CS241002B2 CS748427A CS842774A CS241002B2 CS 241002 B2 CS241002 B2 CS 241002B2 CS 748427 A CS748427 A CS 748427A CS 842774 A CS842774 A CS 842774A CS 241002 B2 CS241002 B2 CS 241002B2
Authority
CS
Czechoslovakia
Prior art keywords
hpi
formula
acid
pyrazino
oxo
Prior art date
Application number
CS748427A
Other languages
Czech (cs)
English (en)
Other versions
CS842774A2 (en
Inventor
Juergen Seubert
Herbert Thomas
Peter Andrews
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=5900929&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CS241002(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Priority to CS778636A priority Critical patent/CS241008B2/cs
Priority to CS778637A priority patent/CS241009B2/cs
Publication of CS842774A2 publication Critical patent/CS842774A2/cs
Publication of CS241002B2 publication Critical patent/CS241002B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Fodder In General (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
CS748427A 1973-12-17 1974-12-11 Method of 2-acyl-4-oxo-haxahydro-4h-pyrazino-(2,1-a-)isoquinoline derivatives preparation CS241002B2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CS778636A CS241008B2 (cs) 1973-12-17 1974-12-11 Způsob přípravy 2-acyl-4-oxo-hexahydro-4H-pyrazino(2,1-a ]- isochinolinových derivátů
CS778637A CS241009B2 (cs) 1973-12-17 1974-12-11 Způsob přípravy 2-acyl-4-oxo-hexahydro-4H-pyrazino(2,1-a)- isochinolinových derivátů

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2362539A DE2362539C2 (de) 1973-12-17 1973-12-17 2-Acyl-4-oxo-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isochinoline, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel

Publications (2)

Publication Number Publication Date
CS842774A2 CS842774A2 (en) 1985-06-13
CS241002B2 true CS241002B2 (en) 1986-03-13

Family

ID=5900929

Family Applications (1)

Application Number Title Priority Date Filing Date
CS748427A CS241002B2 (en) 1973-12-17 1974-12-11 Method of 2-acyl-4-oxo-haxahydro-4h-pyrazino-(2,1-a-)isoquinoline derivatives preparation

Country Status (35)

Country Link
US (1) US4001411A (de)
JP (1) JPS5826352B2 (de)
AR (2) AR208527A1 (de)
AT (1) AT346334B (de)
BE (1) BE823400A (de)
CA (1) CA1036606A (de)
CH (3) CH612195A5 (de)
CS (1) CS241002B2 (de)
DD (1) DD115908A5 (de)
DE (1) DE2362539C2 (de)
DK (1) DK141845C (de)
ES (2) ES432974A1 (de)
FI (1) FI59594C (de)
FR (1) FR2254343B1 (de)
GB (1) GB1441554A (de)
GR (1) GR60708B (de)
GT (1) GT197850798A (de)
HK (1) HK13379A (de)
HU (1) HU170858B (de)
IE (1) IE40124B1 (de)
IL (1) IL46162A (de)
IN (1) IN139511B (de)
IT (1) IT7851978A0 (de)
KE (1) KE2946A (de)
LU (1) LU71204A1 (de)
NL (1) NL185406C (de)
NO (1) NO142304C (de)
OA (1) OA04868A (de)
PH (1) PH14220A (de)
PL (3) PL99088B1 (de)
RO (1) RO66907A (de)
SE (1) SE422211B (de)
SU (3) SU631070A3 (de)
YU (1) YU41288B (de)
ZA (1) ZA747253B (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4196291A (en) * 1973-12-17 1980-04-01 Merck Patent Gesellschaft Mit Beschraenkter Haftung 2-Acyl-4-oxo-pyrazino-isoquinoline derivatives and process for the preparation thereof
US4141978A (en) * 1973-12-17 1979-02-27 Merck Patent Gesellschaft Mit Beschrankter Haftung 2-Acyl-4-oxo-pyrazino-isoquinoline derivatives and process for the preparation thereof
US4162319A (en) * 1974-08-28 1979-07-24 Merck Patent Gesellschaft Mit Beschrankter Haftung Ring substituted pyrazino-isoquinoline derivatives and their preparation
US4120961A (en) * 1974-08-28 1978-10-17 E. Merck Ring substituted pyrazino-isoquinoline derivatives and their preparation
DE2441261A1 (de) * 1974-08-28 1976-03-18 Merck Patent Gmbh Ringsubstituierte pyrazino-isochinolin-derivat und verfahren zu ihrer herstellung
DE2841668A1 (de) * 1978-09-25 1980-04-10 Bayer Ag Medikiertes tierfutter auf basis lebermehl
US4303659A (en) 1979-08-22 1981-12-01 Pfizer Inc. Schistosomicidal compositions
FR2520740A1 (fr) * 1982-01-29 1983-08-05 Sanofi Sa Procede pour la preparation d'acyl-2-hexahydro-1,3,4,6,7,11b-2h-pyrazino (2,1-a) isoquinoleinones-4 et intermediaires
DE3472678D1 (de) * 1983-07-18 1988-08-18 Beecham Group Plc Benzazepine and benzoxazepine derivatives
DE3634755A1 (de) * 1986-10-11 1988-04-14 Bayer Ag Dermale behandlung von wurmerkrankungen der katze mit praziquantel
NZ247278A (en) * 1991-02-12 1995-03-28 Ancare Distributors Veterinary anthelmintic drench comprising a suspension of praziquantel in a liquid carrier
DE19628776A1 (de) 1996-07-17 1998-01-22 Bayer Ag Oral applizierbare Granulate von Hexahydropyrazinderivaten
US6429211B1 (en) 2000-05-23 2002-08-06 Bayer Corporation Praziquantel compounds for treating diseases due to Sarcocystis Neospora Toxoplasma and Isospora
US7396819B2 (en) * 2003-08-08 2008-07-08 Virbac Corporation Anthelmintic formulations
DE10358525A1 (de) * 2003-12-13 2005-07-07 Bayer Healthcare Ag Endoparasitizide Mittel zur topischen Applikation
RU2266906C1 (ru) * 2004-04-29 2005-12-27 Общество с ограниченной ответственностью "Исследовательский Институт Химического Разнообразия" (ООО "Исследовательский Институт Химического Разнообразия") Анелированные карбамоилазагетероциклы, способы их получения (варианты), фармацевтическая композиция, фокусированная библиотека
DE102004055316A1 (de) * 2004-11-16 2006-05-18 Bayer Healthcare Ag Verhinderung vertikaler Endoparasiten-Infektionen
KR100682506B1 (ko) * 2005-01-18 2007-02-15 (주)젠크로스 프라지콴텔, 또는 이의 염을 포함하는 약학 조성물
DE102005011779A1 (de) * 2005-03-11 2006-09-14 Bayer Healthcare Ag Endoparasitizide Mittel
CA2609574A1 (en) * 2005-06-09 2006-12-21 Schering-Plough Ltd. Control of parasites in animals by n-[(phenyloxy)phenyl]-1,1,1-trifluoromethanesulfonamide and n-[(phenylsulfanyl)phenyl]-1,1,1-trifluoromethanesulfonamide derivatives
FR2912145B1 (fr) * 2007-02-02 2009-03-06 Servier Lab Nouveaux derives tricycliques,leur procede de preparation et les compositions pharmaceutiques qui les contiennent
ITPD20070274A1 (it) * 2007-08-08 2009-02-09 Sanypet S P A Crocchetta per animali e metodo per la sua produzione
CA2702577A1 (en) 2007-10-15 2009-04-23 Jbs United, Inc. Method for increasing performance of offspring
DE102008022520A1 (de) 2008-05-07 2009-11-12 Bayer Animal Health Gmbh Feste Arzneimittelformulierung mit verzögerter Freisetzung
AP2909A (en) 2009-03-17 2014-05-31 Concert Pharmaceuticals Inc Pyrazinoisoquinoline Compounds
CN102093346B (zh) * 2010-03-16 2012-09-05 浙江金伯士药业有限公司 一种吡喹酮的制备方法
WO2012122028A2 (en) 2011-03-04 2012-09-13 Concert Pharmaceuticals Inc. Pyrazinoisoquinoline compounds
CN103910725B (zh) * 2013-01-09 2015-12-02 江南大学 一类吡喹酮类似物、其制备方法和用途

Also Published As

Publication number Publication date
DK654274A (de) 1975-08-25
CA1036606A (en) 1978-08-15
SU625613A3 (ru) 1978-09-25
NO744521L (de) 1975-07-14
DE2362539A1 (de) 1975-08-28
IT7851978A0 (it) 1978-11-20
JPS5093999A (de) 1975-07-26
FI59594C (fi) 1981-09-10
RO66907A (ro) 1981-06-26
US4001411A (en) 1977-01-04
GB1441554A (en) 1976-07-07
ZA747253B (en) 1975-11-26
IE40124B1 (en) 1979-03-14
NL7416432A (nl) 1975-06-19
NL185406C (nl) 1990-04-02
SU631070A3 (ru) 1978-10-30
ATA996274A (de) 1978-03-15
JPS5826352B2 (ja) 1983-06-02
CH621788A5 (de) 1981-02-27
CH612195A5 (de) 1979-07-13
FR2254343A1 (de) 1975-07-11
IL46162A0 (en) 1975-02-10
PL94074B1 (de) 1977-07-30
AT346334B (de) 1978-11-10
NO142304C (no) 1980-07-30
OA04868A (fr) 1980-10-31
YU41288B (en) 1987-02-28
ES441546A1 (es) 1977-04-16
GR60708B (en) 1978-07-24
LU71204A1 (de) 1975-04-17
IE40124L (en) 1975-06-17
PL99105B1 (pl) 1978-06-30
IL46162A (en) 1979-01-31
DD115908A5 (de) 1975-10-20
SE422211B (sv) 1982-02-22
GT197850798A (es) 1979-08-01
AR208527A1 (es) 1977-02-15
SU668603A3 (ru) 1979-06-15
SE7415686L (de) 1975-06-18
FI59594B (fi) 1981-05-29
DK141845B (da) 1980-06-30
PH14220A (en) 1981-04-02
KE2946A (en) 1979-04-12
FR2254343B1 (de) 1978-06-30
ES432974A1 (es) 1977-02-16
FI363274A (de) 1975-06-18
BE823400A (fr) 1975-06-16
CH620442A5 (de) 1980-11-28
DK141845C (da) 1980-12-22
YU336174A (en) 1983-01-21
CS842774A2 (en) 1985-06-13
AR208715A1 (es) 1977-02-28
DE2362539C2 (de) 1986-05-07
PL99088B1 (pl) 1978-06-30
AU7643874A (en) 1976-06-17
HK13379A (en) 1979-03-23
HU170858B (hu) 1977-09-28
NL185406B (nl) 1989-11-01
IN139511B (de) 1976-06-26
NO142304B (no) 1980-04-21

Similar Documents

Publication Publication Date Title
CS241002B2 (en) Method of 2-acyl-4-oxo-haxahydro-4h-pyrazino-(2,1-a-)isoquinoline derivatives preparation
SU820659A3 (ru) Способ получени производных 4-амино- 5-АлКилСульфОНилОАНизАМидОВ, иХ СОлЕй,ОКиСЕй, лЕВО- и пРАВОВРАщАющиХизОМЕРОВ /иХ ВАРиАНТы/
AU2013292046C1 (en) Novel 5-aminotetrahydroquinoline-2-carboxylic acids and use thereof
SU812182A3 (ru) Способ получени 7-метокси-1- ОКСАдЕТиАцЕфАлОСпОРиНОВ или иХСОлЕй
JPS62161728A (ja) 抗菌剤
JPH05155858A (ja) トロンボキサン受容体アンタゴニストである新規ベンズイミダゾールおよびアザベンズイミダゾール誘導体、それらの製造方法、およびそれらを含む合成中間体および薬剤組成物
KR20000049154A (ko) 아미노티오펜 카르복실산 아미드 및 포스포디에스테라제 억제제로서의 이들의 용도
CA2666373A1 (en) Heterocyclic compounds useful as anabolic agents for livestock animals
KR20050099525A (ko) 피롤로트리아진 키나제 억제제의 제조 방법
CA3203279A1 (en) Anthelmintic compounds comprising a thienopyridine structure
UA120389C2 (uk) Нові сполуки піридинію
US4051243A (en) Ring substituted pyrazino-isoquinoline derivatives and their preparation
US5411955A (en) Thiadiazinecarboxamide derivatives, processes for their preparation and pharmaceuticals
US4141978A (en) 2-Acyl-4-oxo-pyrazino-isoquinoline derivatives and process for the preparation thereof
US4196291A (en) 2-Acyl-4-oxo-pyrazino-isoquinoline derivatives and process for the preparation thereof
HUT70174A (en) New 3-phenyl-sulphonyl-3,7-diazabicyclo [3.3.1] nonane compounds and pharmaceutical compounds containing the same
US4162319A (en) Ring substituted pyrazino-isoquinoline derivatives and their preparation
FR2470767A1 (fr) Nouveaux iminoacides substitues, leurs procedes de preparation et leur emploi comme inhibiteur d'enzymes
JPH0625178B2 (ja) アミノケトン誘導体及びその用途
WO2019232664A1 (zh) 一类具有消炎免疫活性的磺酰基取代呋喃类化合物及其衍生物
CS241008B2 (cs) Způsob přípravy 2-acyl-4-oxo-hexahydro-4H-pyrazino(2,1-a ]- isochinolinových derivátů
KR800000089B1 (ko) 2-아실 -4-옥소-헥사하이드로-4H-피라지노 [2, 1-a] 이소퀴놀린 유도체의 제조방법
US3993760A (en) Pyrazinoisoquinolines as anthelmintic agents
JPS6117832B2 (de)
US4120961A (en) Ring substituted pyrazino-isoquinoline derivatives and their preparation